Reduction in Left Ventricular Ejection Fraction is Associated with Subsequent Cardiac Events in Outpatients with Chronic Heart Failure.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 11 2019
Historique:
received: 06 05 2019
accepted: 05 11 2019
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 4 11 2020
Statut: epublish

Résumé

Left ventricular ejection fraction (LVEF) is critical for determining the prognosis and treatment of patients with heart failure (HF). However, the influence of serial LVEF changes in patients with stable chronic HF (CHF) has not yet been completely investigated. We analyzed data of 263 outpatients with CHF from the J-MELODIC study cohort and evaluated the frequency of cardiac events. We stratified patients into tertiles based on the relative difference in LVEF in 1 year and that at baseline. We found a significant difference in the cardiac event rate among the three groups (log-rank test, p = 0.042). We identified a relative 11% LVEF reduction as the optimal cutoff value based on the receiver operating characteristics analysis. LVEF (OR, 1.04; 95% CI, 1.01-1.07; p = 0.015) and E/e' (OR, 1.06; 95% CI, 1.01-1.12; p = 0.023) at baseline were predictors of >11% LVEF reduction. After adjusting the variables including age and sex, >11% LVEF reduction was an independent predictor of subsequent cardiac events (HR, 5.79; 95% CI, 2.49-13.2; p < 0.001). In conclusion, patients with 1-year relative >11% LVEF reduction may have subsequent worsening outcomes. Such patients should be carefully followed-up as high risk population for development of cardiac events.

Identifiants

pubmed: 31754155
doi: 10.1038/s41598-019-53697-y
pii: 10.1038/s41598-019-53697-y
pmc: PMC6872762
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17271

Références

J Card Fail. 2004 Jun;10(3):250-7
pubmed: 15190536
Am Heart J. 2016 Sep;179:116-26
pubmed: 27595686
Lancet. 2019 Jan 5;393(10166):61-73
pubmed: 30429050
J Card Fail. 2002 Dec;8(6 Suppl):S476-85
pubmed: 12555161
Am Heart J. 2007 Feb;153(2):237.e1-8
pubmed: 17239682
Sci Rep. 2016 Nov 15;6:37073
pubmed: 27845390
JACC Heart Fail. 2019 Apr;7(4):306-317
pubmed: 30852236
Circ Heart Fail. 2012 Jan;5(1):54-62
pubmed: 22167320
Circ J. 2018 May 25;82(6):1534-1545
pubmed: 29576598
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
J Am Soc Echocardiogr. 2014 Jun;27(6):627-38
pubmed: 24735653
J Card Fail. 2019 Sep;25(9):712-721
pubmed: 30965102
Am Heart J. 2018 Apr;198:91-96
pubmed: 29653653
N Engl J Med. 2011 Oct 6;365(14):1273-83
pubmed: 21991949
Int J Cardiovasc Imaging. 2015 Dec;31(8):1545-51
pubmed: 26239135
Int J Cardiol. 2016 Oct 1;220:750-8
pubmed: 27393861
Eur J Heart Fail. 2017 Oct;19(10):1258-1269
pubmed: 28370829
Eur J Heart Fail. 2014 Mar;16(3):300-8
pubmed: 24464946
J Am Coll Cardiol. 2018 Aug 7;72(6):591-601
pubmed: 30071987
Br J Pharmacol. 2017 Nov;174(21):3727-3748
pubmed: 27714776
J Card Fail. 2019 Jan;25(1):44-50
pubmed: 30448455
Circ J. 2012;76(4):833-42
pubmed: 22451450
Am J Geriatr Cardiol. 2008 Jan-Feb;17(1):13-20
pubmed: 18174755
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
Circ J. 2013;77(2):462-9
pubmed: 23095684

Auteurs

Yoshitaka Okuhara (Y)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan. okuhara@hyo-med.ac.jp.

Masanori Asakura (M)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Yoshiyuki Orihara (Y)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Daisuke Morisawa (D)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Yuki Matsumoto (Y)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Yoshiro Naito (Y)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Takeshi Tsujino (T)

Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan.

Masaharu Ishihara (M)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Tohru Masuyama (T)

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH